Clinical trial
Efficacy of Convalescent Plasma Therapy in Patients With COVID-19: A Randomized Control Trial
NCT04425915 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Convalescent Plasma Therapy in Patients With COVID-19: A Randomized Control Trial
- Lead sponsor
- Institute of Liver and Biliary Sciences, India
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 14, 2020
- Completion date
- December 15, 2020
- Enrollment
- 400 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
covid